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Schlafen, a New Family of Growth Regulatory Genes
that Affect Thymocyte Development
self-MHC molecules. Without this interaction, survival
is severely compromised (Takeda et al., 1996; Rooke et
al., 1997; Tanchot et al., 1997). This finding is consistent
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University of California, San Diego with the observation that in peripheral T cells, certain
components associated with signal transduction suchLa Jolla, California 92093-0687
as the z chain of the T cell receptor complex and ZAP-
70, exist in a phosphorylated state indicative of receptor
engagement (van Oers et al., 1996).Summary
Given that peripheral T cells exist in a resting state, the
signals that mediate survival presumably do not initiateThe Schlafen (Slfn) family of genes are differentially
regulated during thymocyte maturation and are prefer- entry into the cell cycle. Similarly, the process of positive
selection also occurs in the absence of proliferationentially expressed in the lymphoid tissues. Ectopic ex-
pression of the prototype member Slfn1 early in the T (Lundberg and Shortman, 1994; Ernst et al., 1995). Since
both processes are regulated via receptor ligation, anlineage profoundly alters cell growth and develop-
ment. In these mice, the DP thymocytes fail to com- event that normally causes T cell activation and growth,
how are these cells maintained in a quiescent state? Inplete maturation, and, depending on the transgene
dosage, the number of thymocytes is reduced to 1%± part, the solution to this problem may rest in the overall
affinity of the interaction between the TCR and its cog-30% of normal. Furthermore, expression of the Schla-
fen family members in fibroblasts and thymoma cells nate MHC/peptide ligand. Low-affinity interactions may
be sufficient to drive both positive selection and T celleither retards or ablates cell growth. The conceptual
protein sequences deduced for each of the family survival and yet not drive the cells to enter the cell cycle.
However, evidence is accumulating to suggest thatmembers have no similarity to characterized proteins
and must therefore participate in a heretofore un- maintenance of the quiescent state is an active rather
than a passive process. The first indication of this factknown regulatory mechanism guiding both cell growth
and T cell development. was uncovered by Pepperkok and colleagues when they
discovered that fibroblast growth could be inhibited by
Introduction microinjecting cells with RNA from resting T cells (Pep-
perkok et al., 1988). The genetic loci conferring this in-
The production of a functional T cell repertoire requires hibitory effect have yet to be defined but are likely to
that each cell express a clonotypic T cell receptor (TCR) include the recently identified transcription factor LKLF,
that is capable of engaging self-major histocompatibility which appears to be critical in establishing a quiescent
complex (MHC) molecules and yet at the same time is state (Kuo et al., 1997).
not overtly autoreactive. The preponderance of evidence Because of our interest in understanding the biochem-
is consistent with the notion that a critical component ical events that guide thymocyte maturation, we set out
of thymocyte selection is the overall affinity of each TCR to isolate and characterize genes that are differentially
for a combinatorial epitope composed of MHC bound expressed and transcriptionally upregulated as a result
to self-peptides (Ashton-Rickardt et al., 1994; Hogquist of the positive selection process. In so doing, we have
et al., 1994; Sebzda et al., 1994). Those thymocytes that isolated a new family of genes whose members are differ-
lack a minimal affinity for this epitope are deduced to entially regulated during thymocyte development. How-
die from neglect, while thymocytes with too high an ever, while the prototype member of this family is dra-
affinity are deleted from the repertoireÐa process re- matically induced following positive selection, it does
ferred to as negative selection (Kappler et al., 1987). not appear to be required for the selection process.
Thymocytes with an intermediate affinity receive an in- Rather, this gene family is a potent suppressor of cell
ductive stimulus, complete maturation, and become growth, and we suspect that it may be yet another inte-
CD4 or CD8 single-positive (SP) T cells. This latter pro- gral component of the machinery that helps maintain T
cess is referred to as positive selection (Bevan, 1977; cell quiescence.
Zinkernagel et al., 1978).
Like their immature counterparts, peripheral T cells
Resultsexhibit distinct biological responses as a consequence
of the interaction between the TCR and its cognate
Identification and Classification of the SchlafenMHC/peptide ligand, including clonal expansion, blast
Gene Familytransformation, and cytokine secretion. However, recent
The analyses of thymocyte development in vivo havedata suggest that while naive T lymphocytes have a
benefited from the development of TCR transgenic mice.relatively long lifespan in the periphery, their subsis-
Since virtually all T cells in these mice express the sametence is dependent upon the continual engagement of
clonotypic antigen receptor, the population is uniformly
subjected to the processes of positive and negative
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selection. This property permits the manipulation of theucsd.edu).
selection process by altering the MHC molecules en-² Present Address: Neurocrine Biosciences, Inc., 10555 Science
Center Drive, San Diego, CA 92121-1102. countered during development. For instance, in mice
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Figure 1. Comparison of the Schlafen Family
Deduced Amino Acid Sequences
Comparison of the deduced amino acid se-
quences of the four complete Schlafen family
genes. Conserved amino acids are boxed
while identical sequences are shaded. The
underlined regions define conserved se-
quence blocks identified using BlockMaker.
The asterisk marks the location of the methio-
nine residues that potentially could reside at
the amino terminal end of each protein.
expressing the AND TCR specific for cytochrome c, and screen a mouse genomic library, resulting in the isolation
of a series of clones that encode all or part of Slfn3, 4,the H-2h4 haplotype (AND.4R mice), maturation is halted
at the CD4181 double-positive (DP) stage, and these and 6, as well as one additional clone that we have
designated Slfn7. Based on these data, we estimate thatmice lack mature CD4 or CD8 SP cells (Kersh and Hed-
rick, 1995). In contrast, development is skewed toward the Slfn family consists of at least seven distinct genes.
Each Slfn cDNA encodes a single long open readingthe positive selection of CD4 SP cells in AND mice ex-
pressing H-2b (AND.B6 mice), and these cells constitute frame that is initiated by a consensus translational initia-
tion codon (Kozak, 1986) and is preceded upstream by50% of all thymocytes (Kaye et al., 1989, 1992).
To identify genes that are upregulated as a result one or more in frame termination codons. In three of
the genes (Slfn1, 2, and 4), an internal Kozak initiationof positive selection, a subtractive hybridization was
performed using thymus cDNA libraries prepared from codon is found corresponding to amino acid position
28 of SLFN1, and it is unclear which initiation codonAND.B6 and AND.4R mice. The objective was to charac-
terize genes from the AND.B6 library not in common is utilized by the mature protein; however, since the
upstream methionine codon is missing from Slfn3, it iswith the AND.4R library. This led to the isolation of a
novel developmentally regulated gene that is preferen- conceivable that all four proteins preferentially use this
internal initiation site.tially expressed in AND.B6 compared to AND.4R thymo-
cytes (Figure 2A). The nucleotide and deduced amino The four conceptual SLFN proteins contain a core
region that is nearly identical, spanning amino acidsacid sequences of this gene, which we have named
Schlafen1 (Slfn1), were used to query the expressed 213±336 of SLFN1; however, the N terminus for each of
the four proteins differs significantly. The exception issequence tag (EST) databases using the gapped-basic
local alignment search tool (BLAST) (Altschul et al., between SLFN3 and 4, which are very similar except for
a deletion of 10 amino acids in SLFN4. Interestingly,1997). This approach ultimately led to the isolation of
three additional Slfn genes (Figure 1) that collectively while SLFN1 and 2 are almost identical in size, SLFN3
and 4 are nearly twice as large, possessing a carboxy-bear identity or similarity to 53 EST entries. Based on a
sequence comparison, these ESTs have been assigned terminal protein sequence of approximately 200 amino
acids not found in SLFN1 or 2. We refer to these regions,to six unique genes. Expression of each of these genes
has been confirmed by rtPCR (below and data not based on the amino acid sequence of SLFN3, as domain
I (amino acids 1±186), II (amino acids 187±309), and IIIshown). A portion of the Slfn3 cDNA was also used to
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Figure 2. Analysis of Schlafen Messenger
RNA Expression
(A) Total RNA was isolated from the thymi of
AND mice and analyzed by Northern hybrid-
ization using radiolabeled Slfn1 cDNA. Alter-
natively, rtPCR analysis was used to measure
message expression in the indicated organs
(B), thymic subsets (C), or resting versus acti-
vated T cells (D). These data are representa-
tive of two experiments that were performed
using different primer cocktails. (E) The area
encompassed by each PCR product in the
undiluted cDNA time points from (D) was cal-
culated, and the area of each Slfn gene was
normalized relative to actin and plotted.
(amino acids 310±517). Although we have no information ORFs encode a functional protein that affects viral repli-
cation or host cell function. In the absence of nonviralto indicate that these regions constitute actual protein
domains, domain III of both SLFN3 and 4 are encoded homologs at either the nucleotide or protein level, the
analysis of each family member was extended to identifyby a unique exon, while domains I and II are contained
within a single exon (data not shown). any putative domain structures in each SLFN protein.
The most recent releases of the PROSITE (Bairoch et
al., 1997), BLOCKS (Henikoff and Henikoff, 1994), andAnalysis of Schlafen Family Sequences
PRINTS (Attwood et al., 1998) databases were queried.Using gapped-BLASTn to query the nonredundant DNA
In no case were multiple members of a motif ªfamilyºdatabases, we found that the nucleotide sequences of
present. We also used Block Maker (Henikoff et al., 1995)Slfn1-4 do not share meaningful similarities to any known
to identify two conserved motifs that were defined usinggenes. In contrast, a number of significant matches were
SLFN1-4, along with the partial sequence for the humanfound when the deduced SLFN amino acid sequences
homolog of SLFN5. These motifs, which are underlinedwere used to query the nonredundant protein databases
in Figure 1, were used to query the nonredundant proteinusing BLASTp. In each case, strong matches were found
databases using the local alignment of multiple align-in the right inverted terminal repeat (ITR) of Vaccinia,
ments (LAMA) search tool (Pietrokovski, 1996). Again, asVariola, and Cowpox viruses. Located within this region
we saw using the individual sequences as query vectors,are the putative proteins referred to as B2R, 20.9k, B3,
there were no significant matches found.H3R, and H5R. Upon closer examination, it was found
that the nucleotide sequences of these viral isolates are
very similar to those for the Slfn family; however, with Expression of Schlafen Family Members
The Slfn genes are expressed at relatively low levels asthe exception of B2R, the similarity is not found within
a single ORF but rather is distributed through all three detected by Northern blot analysis (Figure 2A; data not
shown), so we have utilized rtPCR to measure the ex-ORFs. We suspect that a member of the Slfn family was
captured early on in the evolution of this viral family and pression of each gene. Primer cocktails were used that
target the nucleotide sequences encoding the variablehas been slowly decaying over time. Nonetheless, there
exists the possibility that one or more of the putative domain I and conserved domain II of each gene. In this
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way, we could accomplish the simultaneous amplifica- vector contains a ribosomal entry site that allows trans-
lation of both the gene of interest and the downstreamtion of all four genes in a single reaction. As a control,
an additional primer set specific for b actin was included neomycin phosphotransferase message. As a direct
consequence, all transfected cells that are neomycinin all reactions. We note that the primer sets for Slfn3
and 4 also amplify Slfn6 and 7, respectively. resistant must also express Slfn.
Figure 3A is a pictorial of three independent experi-As shown in Figure 2B, Slfn1, 2, and 4/7 were found
to be mainly expressed in the thymus, lymph node, and ments using this expression system. In each case, trans-
fection of NIH-3T6 cells with pCIN-4 alone resulted inspleen. There was low-level expression in other tissues,
especially the lung, but these samples probably con- innumerable drug resistant colonies, while no colonies
could be detected in mock transfected cultures. How-tained circulating lymphocytes. The highest level of
Slfn3/6 expression was detected in the testis, although ever, cells transfected with pCIN-4 vectors encoding
Slfn genes had a variable effect on the generation ofthere was a small amount detected in the thymus and
heart. Complement-mediated depletion of thy-11 sple- drug-resistant colonies. With Slfn1, there was a notice-
able reduction in the number of colonies recovered rela-nocytes removed most of the Slfn1 signal (data not
shown), demonstrating that much of the expression can tive to vector alone. However, for Slfn2 and 3, there
was a dramatic reduction in the number of coloniesbe attributed to the T cell subset. Conversely, we failed
to find expression of Slfn4/7 in purified T cells (Figure observed, with only a single colony produced in all three
independent transfections with Slfn3. Similar results2D), and presumably expression in the spleen and lymph
nodes can be attributed to other cell types. were also obtained using the thymoma AKR1G1 in a
colony formation assay (data not shown). This presentsWe next examined expression of each gene in the
four major thymic subsets: immature CD32CD42CD82 an enigma, since AKR1 expresses a member of the Slfn
family that is amplified by the Slfn3 primer set (data nottriple-negative cells (TN), CD41CD81 DP cells, and ma-
ture CD4 or CD8 cells. In order to quantitate the relative shown), and yet transfection appears to prevent colony
formation. We are currently attempting to determineexpression in each subset, serial 10-fold dilutions of cDNA
were PCR amplified, and all signals were normalized to whether the detected transcript might encode a mutant
form of Slfn3 or whether our primers are detecting theb actin. As shown in Figure 2C, Slfn1 was upregulated
approximately 100-fold during the DP to SP transition. closely related Slfn6, which we have yet to assay for
growth disruption. Alternatively, colony formation maySlfn2 expression also increased during this transition,
but the increase was found to be only 5- to 10-fold. depend on the relative level of Slfn3 expression.
The above data are consistent with the possibility thatInterestingly, Slfn4/7expression decreased during de-
velopment, being the highest in TN cells and barely Slfn family members arrest cell growth, or cause apopto-
sis, or both. To account for the loss of Slfn-expressingdetectable in SP cells. Finally, Slfn3/6 message is ex-
pressed very weakly, but the level of its expression does cells, we placed Slfn1 under control of the tetracycline
operator (Shockett et al., 1995) and introduced this syn-not appear to change dramatically. Collectively, these
data show that Slfn1, 2, and 4/7 are preferentially ex- thetic gene into NIH-3T3 fibroblasts expressing the tet-
racycline responsive transactivator (S2-6 cells, a gener-pressed in the lymphoid lineage and are differentially
regulated during thymocyte development. ous gift from David Schatz). In these cells, expression
of the transgene is suppressed in the presence of tetra-We also examined the expression of Slfn genes under
conditions of T cell activation. Peripheral T cells were cycline and is induced following tetracycline removal.
To test the effect of Slfn1 on cell growth, expressionpurified and left untreated or subjected to plate-bound
anti-CD3 in the presence or absence of CD28 costimula- was induced for periods of 24, 48, or 72 hr. In preliminary
experiments, we found a strong inhibition of cell growthtion for either 1, 2, or 3 days. Untreated T cells expressed
both Slfn1 and 2 but not 3/6 or 4/7 (Figure 2D). Following in the Slfn1-transfected clone but not in S2-6 clones.
To determine the percentage of cells that were in G0/T cell activation, there was an increase in the expression
of Slfn3/6 and 4/7 and a concomitant decrease in the G1, S, and G2/M at different times after Slfn1 induction,
the cells were stained with propidium iodide to measureexpression of Slfn1 and 2 (Figure 2E). Interestingly, these
changes were more pronounced following ligation of DNA content, and DNA synthesis was assessed by mea-
suring the incorporation of a single pulse of BrdU.both CD3 and CD28. This may indicate that the expres-
Figure 3B depicts results that are representative ofsion of the Slfn gene family is linked to cell growth or
three independent experiments. Prior to induction, theblastogenesis.
cell density in each culture was similar for the parental
S2-6 cells and the Slfn1 transfected clone, 18-9. Approx-
Slfn Inhibits Cell Growth imately 30% of the cells were in S phase, and 9% were
Early attempts to produce cell lines that constitutively in G2/M. Over the course of the experiment, the percent-
expressed Slfn1 were unsuccessful. We also found that age of control S2-6 cells in S and G2/M remained rela-
neither antigen-specific T cell clones nor primary T cell tively constant until the cells reached confluence at 72
lineage transformed cell lines expressed Slfn1 (data not hr. Once confluent, these cells became quiescent and
shown). Since we had already found a tentative link the percentage in S phase dropped. Conversely, induc-
between expression of the Slfn genes and cell growth tion of Slfn1 in 18-9 cells reduced the percentage in S
(see above), we reasoned that ectopic expression of the phase within 24 hr, and there was no further increase
Slfn family might alter normal cell growth. To test this in the number of cells recovered after this time point.
hypothesis, cDNA clones for Slfn1-3 were cloned into Interestingly, the percentage of 18-9 cells in S phase
increased at 72 hr, even though the density remainedthe expression vector pCIN-4 (Rees et al., 1996). This
Schlafen Regulates Cell Growth
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Figure 3. Effect of Ectopic Slfn1 Expression
on Cell Growth
(A) Schlafen cDNAs were cloned into pCIN-4,
which encodes both the gene of interest and
neomycin phosphotransferase in a single bi-
cistronic message. NIH-3T6 fibroblasts were
transfected with the indicated constructs and
drug-resistant colonies were counterstained
with hematoxylin.
(B) Slfn1 was placed under control of the tet-
racycline operator and transfected into S2-6
fibroblasts that express a tetracycline re-
sponsive transactivator. Slfn1 expression
was induced by removing tetracycline for the
indicated time intervals. The effect on the cell
cycle of Slfn1-expressing cells (18-9) relative
to parental cells (S2-6) was assessed by si-
multaneously measuring the incorporation of
BrdU and propidium iodide. The number of
cells recovered is indicated in the upper left-
hand corner. In the lower right-hand corner,
the percentage of cells in G0/G1 (lower left
region), S (upper region), and G2/M (lower
right region) are indicated.
unchanged. This is consistent with our observation of double negatives (DNs), and expression persists in ma-
ture peripheral T cells. Of 39 live births, two foundera gradual increase in 18-9 growth following 4 days of
Slfn1 expression (D.A.S. and S. Gray, data not shown). lines were identified (Slfn14 and Slfn17). Only the Slfn14
line (subsequently referred to as CD2.Slfn1) expressedCollectively, these data demonstrate that Slfn1 inhibits
the G1 to S phase transition of the cell cycle. We de- the transgene. The level to which the transgene is ex-
pressed is slightly less than that detected for the endog-tected no change in cell viability at any point during Slfn1
expression, as assessed by either trypan blue uptake or enous message in normal peripheral lymphocytes (Fig-
ure 4A). However, in the thymus, expression of thethe quantitation of subdiploid amounts of DNA. This
appears to exclude apoptosis as the method by which transgene predominates, and presumably reflects the
loss of the SP cells (see below), which are the primaryfibroblast growth is disrupted. We have been unable to
carry out similar experiments with Slfn2 or Slfn3 because source of endogenous Slfn1 message (Figure 2C). We
emphasize that Slfn1 is not overexpressed in CD2.Slfn1we cannot obtain stable S2-6 transfectants. The basal
expression of Slfn2 or 3 in this system may be sufficient mice. Rather, we have altered the kinetics of its expres-
sion such that DP thymocytes express levels normallyto disrupt cell growth.
found in SP thymocytes.
The FACS profiles depicted in Figure 4B are represen-Ectopic Early Expression of Slfn1 Disrupts
tative of several independent experiments, while theThymic Development
number of cells in each subset were calculated from theBased on the observations that Slfn1 causes a cell cycle
collective data of 11 littermate, 13 CD2.Slfn11/2, and 7arrest, we wanted to determine whether SLFN partici-
CD2.Slfn11/1 mice. All mice ranged in age from 40±50pates in regulating thymocyte expansion or maintaining
days, and identical quadrants were set in each experi-mature thymocytes in a quiescent state. To accomplish
ment. As shown, early expression of Slfn1 caused athis, we produced transgenic mice using a Slfn1 cDNA
severe reduction in overall thymus size, such that theunder the transcriptional control of the human CD2 pro-
thymi of CD2.Slfn11/2 mice contain only 10% to 30% ofmoter/enhancer/locus control region. This combination
the thymocytes found in littermate control (LMC) mice.of regulatory elements drives dose-dependent transgene
expression in all thymocyte lineages including the CD4282 If expression was increased 2-fold by generating mice
Immunity
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Figure 4. Effect of Ectopic Slfn1 Expression
on Thymocyte Development and Cellularity
(A) Steady-state message levels in the thymi
and lymph nodes of CD2.Slfn11/2 transgenic
mice were measured by probing a Northern
blot with the Slfn1 cDNA. RNA from select
tissues of normal mice are included for com-
parison. The transgene encodes a message
that is slightly smaller than its endogenous
counterpart.
(B) The expression of CD4 and CD8 was mea-
sured on thymocytes from the indicated mice
and the number of cells (3 1026) representing
each subset is shown.
(C and D) Electronic gates were set on the
CD4 or CD8 subsets, respectively, and the
expression of CD3 was measured.
(E) Representative data of CD4 and CD8 ex-
pression on splenocytes prepared from the
indicated mice.
homozygous for the transgene, the thymi contained only mice, both of which contain thymocytes that are ar-
rested early in development (Mombaerts et al., 1992a,1%±3% of the cells found in LMC mice.
While ectopic expression of Slfn1 reduced thymic cel- 1992b). We know of no other transgene that evokes such
a dramatic alteration in T cell development. Consideringlularity as anticipated, there was also a severe alteration
in development. This was readily evident from the thy- that the protein sequence is unaltered, the expression
level is physiological, and the gene is naturally ex-mus subpopulations (Figure 4B), and we found it to be
exaggerated in the peripheral lymphoid organs (Figure pressed (later) in the same lineage, this exquisite disrup-
tion of development is remarkable.4E). Homozygous transgenic mice exhibited a profound
loss of SP thymocytes and T cells. Although a large
population of CD4 SP cells was found within the thymus
of the transgenic mice, most of these cells appear to CD2.Slfn1 Disrupts Thymocyte Division
The reduction in thymic cellularity, particularly inbe immature since they expressed little or no CD3 (Fig-
ure 4C) but high levels of the heat stable antigen typically CD2.Slfn11/1 mice, is consistent with a disruption in
thymocyte progression through cell division. This wasfound on immature thymocytes (data not shown). This
is in direct contrast to the small number of CD8 cells assessed by measuring the incorporation of a single in
vivo pulse of the thymidine analog BrdU into DN thymo-that are relatively normal in their expression of CD3
(Figure 4D). Interestingly, as the transgene dosage in- cytes from wild-type or CD2.Slfn11/1 mice. Thymocytes
were stained with antibodies to CD4, CD8, and BrdUcreases, there is a coordinate appearance of a popula-
tion of CD4lo cells that may be the precursor to the DN (Figure 5A), and BrdU incorporation was measured by
setting an electronic gate on the DN subset. Twentysubset (Wu et al., 1991b). These cells may accumulate
as a consequence of an early developmental block in percent of DN thymocytes from wild-type mice were
positive for BrdU incorporation (Figure 5B), and this cor-thymocyte expansion, particularly since a similar popu-
lation is observed in RAG and TCRb chain±deficient responds closely with published data (Penit et al., 1995).
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Figure 5. Effect of Ectopic Slfn1 Expression
on Thymocyte Proliferation
(A) Mice were administered a single dose of
the thymidine analog BrdU, and 24 hr later
thymocytes were fixed and triple-stained with
antibodies specific for BrdU, CD4, and CD8.
The expression of CD4 and CD8 is shown for
the indicated mice.
(B) Electronic gates were set on the DN sub-
sets shown in (A), and the percentage of BrdU
positive cells was measured.
(C) Thymocytes were treated with anti-CD3,
-CD4, and -CD8 plus complement and the
resulting cells stained with antibodies spe-
cific for CD4, CD25, and CD44. The percent-
age of CD42 cells expressing the indicated
markers is shown in each quadrant.
The ectopic expression of Slfn1 inhibited the prolifera- they appear to upregulate CD25 and then downregulate
CD44. In the CD251442 subset, TCRb chain rearrange-tion of the DN cells, as only 10% of these cells incorpo-
rated BrdU. Note that the fixation of the cells during ment takes place, and a productive rearrangement pro-
motes entry into the cell cycle (Falk et al., 1996; Hoffmanstaining caused a slight alteration in the bivariate profile
(Figure 5A), making it impossible to distinguish the DN et al., 1996). The cells subsequently downregulate CD25
to become CD442252. A similar analysis performed withand CD4lo subset in the transgenic mice. However, since
the CD4lo subset was shown to have an activated pheno- CD2.Slfn11/1 mice revealed that the vast majority (58%)
of CD324282 thymocytes are arrested at the CD251442type (Wu et al., 1991a), it is likely that these cells are
cycling, and they would therefore be expected to in- stage of development (Figure 5C). This is the same
stage at which RAG-deficient thymocyte developmentcrease the percentage of BrdU1 cells in the DN subset.
Thus, the overall inhibition of DN division may be greater is blocked and is consistent with the idea that ectopic
Slfn1 expression interferes with the proliferative expan-than shown.
Immature DN thymocytes are developmentally hetero- sion of CD252442 thymocytes. Interestingly, there was
also a reduction in the percentage of CD252441 cells.geneous, and these cells can be further fractionated
based on the expression of CD25 and CD44. These It may be that Slfn1 expression also blocked the IL-7-
driven proliferation of these cells. Alternatively, excessmarkers alone define four distinct subsets within the DN
subset (Figure 5C). The most immature cells express CD251 cells may have inhibited the expansion of the
CD252441 cells through an unspecified feedback mech-CD44 only, and these cells divide in response to intra-
thymic IL-7 (Peschon et al., 1994). As the cells mature, anism.
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Figure 6. Effect of Ectopic Slfn1 Expression
on Thymocyte Viability
(A) Cell viability was measured by flow cytom-
etry. Dead cells can be distinguished based
on their decrease in cell size (forward light
scatter [FSC]) and increase in granularity (908
light scatter [SSC]). The percentage of live
cells is shown.
(B) Thymocytes were stained with DiOC6,
which measures alterations in the mitochon-
drial proton gradient. A decrease in DiOC6
staining in the gated live cell population is
indicative of cells undergoing early stages of
apoptosis.
CD2.Slfn1 Thymocytes Are Apoptotic the Slfn1 gene (Figure 7). In embarking on this line of
experimentation, our concern was that there are multipleThe process of T cell development in the thymus is
known to involve a high rate of cell death (Weissman et members of the Slfn family, and at least Slfn1-3 are
potentially capable of inhibiting cell growth. However,al., 1975; Jenkinson et al., 1989; Zacharchuk et al., 1991),
although there is also a coordinate capacity for the en- if these members were not functionally redundant, we
hypothesized that the loss of Slfn1 would result in hyper-gulfment of apoptotic thymocytes (Surh and Sprent,
1994). Free, apoptotic thymocytes are thus rare in freshly proliferative disorders and perhaps even tumor for-
mation.explanted thymocytes. However, using forward and side
scatter parameters to measure cell size and granularity, The coding region for Slfn1 is located on a single exon
(Figure 7A) and it was targeted for deletion by a completewe readily noticed an unusually large percentage of
dead cells in thymi isolated from CD2.Slfn1 transgenic replacement with tk-neo. A total of four ES cell clones
hemizygous for Slfn1 were generated (Figure 7B), ofmice (Figure 6A). While 86% of thymocytes from LMC
mice were viable, more than half the thymocytes were which two led to germline transmission. Using rtPCR, we
confirmed that there was no remaining Slfn1 message indead in CD2.Slfn11/1 mice. This was confirmed by mea-
suring the extent of DNA fragmentation in the explanted mice with a homozygous deficiency (Figure 7C). Mice
were analyzed for changes in thymus cellularity or alter-thymocyte suspensions by TUNEL (terminal deoxy-
nucleotidyl transferase-mediated dUTP-biotin nick end ations in the expression of a variety of cell surface mark-
ers including CD4 and CD8 on both thymocytes (Figurelabeling) (data not shown).
The morphological changes associated with apopto- 7D) and peripheral lymphocytes (Figure 7E). No pheno-
typic differences between Slfn1-deficient mice and theirsis occur relatively late in the death pathway, whereas
earlier stages of apoptosis can be detected by measur- LMC counterparts have been noted thus far, and we
conclude that Slfn1 is not required for these aspects ofing changes in the proton gradient maintained across
lymphoid physiology. We suspect that one of the otherthe inner mitochondrial membrane. As cells undergo
family members may indeed be compensating for theapoptosis, the membrane potential drops, and this can
loss of Slfn1. In particular, Slfn2 is similar to Slfn1 inbe measured as a reduction in the intensity of DiOC6
both size and expression. We are currently attemptingstaining (Zamzami et al., 1995). As shown in the experi-
to address this issue by producing mice deficient forment depicted in Figure 6B, 32% of the viable cells from
multiple Slfn family members.CD2.Slfn11/1 mice were DiOC6 low as compared to 11%
in thymocytes from a LMC mouse. Thus, using three
independent measures, we found a significant increase Discussion
in the number of apoptotic thymocytes isolated from
Slfn1 transgenic mice. In each case, the phenotype of We have identified a novel gene family that consists, in
CD2.Slfn11/1 mice was an exaggeration of that seen mice, of at least seven highly related members. These
in CD2.Slfn11/2 heterozygotes. We conclude that the genes encode proteins that fall into two distinct groups
observed reduction in thymic cellularity appears to be based on size; a short form encoded by Slfn1 and 2 and
a consequence not only of reduced cell division but of a long form encoded by Slfn3 through 7. The prototype
increased cell death. member of this family, Slfn1, was isolated in a screen
designed to identify genes that are transcriptionally
upregulated during the process of positive selection.
Slfn1-Deficient Mice While we have demonstrated a large increase in the
In order to determine whether Slfn1 expression is re- expression of this gene during thymocyte development,
quired for normal regulation of thymocyte expansion, we also found that there is a substantial difference in
the expression of at least two other family memberswe produced mice with a homozygous deficiency in
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Figure 7. Analysis of Slfn1-Deficient Mice
(A) The second exon of Slfn1, which contains
the putative ORF in its entirety (shaded box),
was replaced with the neomycin cassette. E,
EcoRI; S, SacI; A, AvaI; H, HindIII; B, BamHI.
(B) Four distinct Slfn1 hemizygous ES cell
clones were isolated, two of which (H7 and
E9) resulted in germline transmission of the
disrupted locus. (C) Total RNA was isolated
from the thymi and lymph nodes of the H7
line of mice and subjected to RT-PCR using
primers that span the 4.2 Kbp intron separat-
ing exons 1 and 2. Actin primers were in-
cluded in each reaction to monitor amplifica-
tion. Single cell suspensions were prepared
from the thymus (D) and pooled lymph nodes
(E) of H7 line mice. CD4 and CD8 expression
was analyzed by flow cytometry and the per-
centage of cells in each quadrant is indi-
cated.
during maturation. Comparing the DP and SP stages of cell cycle. Furthermore, this growth inhibition can be
reversed by terminating gene expression (data notdevelopment, both Slfn1 and 2 are upregulated, whereas
Slfn 4 is downregulated. The precise point of regulation shown). Hence, the family has been named Schlafen,
which is the German word meaning ªto sleep.º The ef-is not yet known but preliminary evidence indicates that
it depends upon positive selection. For instance, there fects of Slfn1 on cell growth in vitro are the weakest
of the group as measured by colony counts in stableis a failure of Slfn1 upregulation in two types of mice
deficient in positive selection: MHC-deficient mice (D.A.S., transfections, and, as mentioned above, thus far we
have been unable to generate inducible versions of Slfn2J. Kaye, and S.M.H., unpublished data) and TCR trans-
genic mice with a nonselecting MHC haplotype (AND.4R or 3 using the tetracycline-repressible promoter.
The primary amino acid sequence for each of theTCR transgenic mice). We propose that changes in the
expression of Slfn1, 2, and 4 occur as a part of the four family members provides no clue to their potential
function. We have also used The Jackson Laboratoriesprogram of mature T cell differentiation and may contrib-
ute to the phenotypic differences noted for each thymic C57BL/6 3 M. spretus interspecific backcross panel
(Rowe et al., 1994) to map the chromosomal location ofsubset.
Although early ectopic expression of Slfn1 has a pro- both Slfn1 and 2. Both of these genes map to a position
on mouse chromosome 11 that lies in the vicinity offound effect on thymocyte development, the most prom-
inent attribute of this gene family is their effect on cell the CC chemokine family (D.A.S., unpublished data);
however, they bear no similarity to this family other thangrowth and progression through the cell cycle. Using a
repressible promoter system to drive the expression of having two adjacent cysteines. Thus, none of the data
collected to date have provided a clear picture on theSlfn1, we found that the induction of Slfn1 causes a cell
cycle arrest such that cells fail to initiate DNA synthesis mechanism by which the SLFN molecules exert their
effect. Despite this, the preponderance of data thus farand are consequently arrested at the G0/G1 stage of the
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hybridized at high stringency with an 800 bp EcoRI/NotI fragmentsuggests that the SLFN molecules almost certainly par-
from the I.M.A.G.E. consortium clone 332469 (GenBank W08491),ticipate in the regulation of the cell cycle. These data
and 12 individual clones were isolated. Subclones in pBluescriptinclude: (1) the cytostatic effects seen in fibroblasts and
SK(-) were excised with helper phage and sequenced from both
AKR1 cells; (2) a reduction in the expression of Slfn1 ends. Eleven of the twelve clones shared identity with the EST clone
and 2 following induction of T cell proliferation; (3) the 332469 (Slfn2), while only one was different (Slfn3). The longest Slfn2
cDNA (GenBank AF099973) and Slfn3 (GenBank AF099974) wereloss of Slfn1 expression, and to a lesser extent Slfn2
sequenced completely on both strands.expression, in long-term T cell tumors and clones (data
To derive the amino acid sequence of Slfn4, the I.M.A.G.E. consor-not shown); and (4) the reduction in thymic cellularity
tium clone 638739 was sequenced on both strands (GenBankobserved in CD2.Slfn1 transgenic mice.
AF099975). The oligonucleotides Slfn3B.5 and Slfn4/430 were then
Although we have demonstrated that the reduction in used in rtPCR to amplify a partial clone from splenic polyA1 RNA
thymic cellularity can be attributed at least in part to a (GenBank AF099976). This clone was sequenced on both strands
and compared to a genomic clone to account for errors introduceddecreased rate of cell division, we also found an unusu-
by either reverse-transcriptase or Taq polymerase. Based on theseally high amount of cell death in freshly explanted thymi.
sequences, two new oligonucleotides were synthesized (Slfn4/385Because of the block in cell growth imposed by Slfn1,
and Slfn4/-52) that were used to sequence a genomic clone encod-this death may result from inductive stimuli received
ing the presumptive translation initiation site and an upstream stop
through the TCR that are subsequently unable to initiate codon (GenBank AF099977).
progression through the cell cycle. This is reminiscent To compare the deduced amino acid sequence of each gene, the
sequences were first aligned using Clustal W version 1.5 (Thompsonof the apoptosis observed when c-myc is induced in
et al., 1994) and then imported into SeqVu version 1.0 (The Garvangrowth-arrested cells (Evan et al., 1994; Dou et al., 1995;
Institute of Medical Research) for graphical presentation.Morse et al., 1997; Murata et al., 1997). In fact, c-myc
expression is differentially regulated during thymocyte
Purification and Activation of Peripheral T Cells
maturation; the highest levels are found in the TN thymo- Lymphocytes were pooled from the lymph nodes of 4- to 8-week-
cytes, and expression decreases in DP cells expressing old adult mice and resuspended in RPMI complete (RPMI-1640,
low levels of CD3 prior to being upregulated again in 10% FCS, 1 mM sodium pyruvate (Irvine Scientific), 13 nonessential
amino acids (Irvine Scientific), 2 mM L-glutamine, 5 3 1025 2-mer-the mature SP cells (Broussard-Diehl et al., 1996). Since
captoethanol, and antibiotics). The cells were adsorbed to plasticc-myc is expressed at very high levels at the same devel-
for 1 hr at 378C to remove macrophages and dendritic cells, and Bopmental stage in which proliferation is blocked in the
cells were removed using sheep anti-mouse IgG magnetic beads
transgenic mice, this is likely to account for the massive (Dynal). Six centimeter dishes were coated with 10 mg/ml goat anti-
death seen in these thymi. hamster Ig for 1 hr at 378C in carbonate buffer. Plates were washed,
As of now, we cannot put forth a mechanistic hypothe- and purified anti-CD3 (145.2C11) was added at a concentration of
100 ng/ml in growth media and allowed to incubate for 1 hr at 378C.sis to explain the function of the Slfn gene products.
Plates were washed again and 3 3 106 cells were added in theThey clearly must be carefully regulated since relatively
presence or absence of a 1:20,000 dilution of anti-CD28 ascitessmall changes in expression can completely disregulate
(Gross et al., 1992) and cultured for the indicated time period at
cell growth and cell death. SLFN must act on the funda- 378C.
mental machinery involved with cell cycle control since
even the lymphocyte-specific members can arrest growth Purification of Thymocyte Subsets
of fibroblasts. Beyond this, we need to know how SLFN Thymocytes from adult B10.A female mice were treated for 45 min
with Low-tox rabbit complement (Cedarlane Laboratories) and anti-perturbs the cell cycle, and the identity of the molecules
bodies specific for CD4 (RL172) and/or CD8 (3.168.36). Treated cellswith which it interacts. Although the primary sequences
were then stained on ice for 1 hr (see below) and the appropriateof the hypothetical proteins have not revealed any mech-
subsets electronically sorted using a Becton-Dickinson FACStar.
anistic secrets, perhaps the solution of the tertiary pro- Alternatively, CD324282 cells were purified by treating with comple-
tein structure or the identification of interacting proteins ment and the same antibodies described above supplemented with
would suggest a function. Our conclusion is that this the anti-CD3 antibody C363-29B.
novel family of proteins must participate in a heretofore
Preparation and Analysis of RNAunknown regulatory mechanism guiding both cell growth
Total RNA was prepared using either Trizol reagent (GIBCO-BRL)and T cell development.
or RNeasy spin columns (Qiagen) following the manufacturer's pro-
tocol. For Northern blot analysis, 30 mg of total RNA was resolved
through a 1% formaldehyde gel, transferred to NitroPure nitrocellu-Experimental Procedures
lose (Micron Separations Incorporated), and hybridized to a radiola-
beled Slfn1 cDNA probe. For rtPCR analysis, total RNA was treatedIsolation and Sequencing of Schlafen cDNAs
PolyA1 RNA from AND.B6 and AND.4R thymocytes was isolated with Rnase-free Dnase and converted to cDNA with AMV reverse
transcriptase. Two hundred nanograms (or 2 3 105 cell equivalentsusing a QuickPrep Micro mRNA purification kit (Pharmacia). Com-
plementary DNA libraries were prepared using a Superscript plasmid in the case of the thymocyte subsets) of the resulting samples were
subjected to 30 cycles of the PCR in a 25 mL buffered solutioncDNA library kit (GIBCO-BRL) according to the manufacturer's rec-
ommended protocol. Inserts excised from the plasmid backbone containing 1.5 mM Mg11 and either 10 pmoles (SlfnORF5, Slfn2B.5,
Slfn3D.5, Slfn4.5, b-Actin3, and b-Actin5) or 30 pmoles (Slfn4/B)were used for subtractive hybridization using a previously described
protocol (Hara et al., 1994). Subtracted material was subcloned into primer. For analysis of Slfn1-deficient mice, 10 pmoles each of
18.RTP3, 18.RTP5, b-Actin3, and b-Actin5 primers were used. ThepBK-CMV (Stratagene), and a single cDNA clone encoding Slfn1
(GenBank AF099972) was recovered. Subclones of the Slfn1 cDNA individual cycles were 20 sec at 958C, 40 sec at 578C, and 60 sec
at 728C. One half of the amplified material was resolved through anwere sequenced on both strands using the Sanger dideoxy chain
termination method. The orientation and placement of each sub- agarose gel containing EtBr and the image captured electronically
using IPLab Gel H software (Signal Analytics). In the case of acti-clone was determined by restriction mapping or by sequencing
additional overlapping clones. vated T cells, a profile plot representing band intensity was gener-
ated for each PCR product series (for example, Slfn1 at each timeTo isolate Slfn2 and 3, a C57BL/6 thymocyte cDNA library was
prepared in the l vector UNI-ZAP (Stratagene). The library was point) using IPLab Gel H software. The area (A) of each peak was
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then calculated. For each time point (for example, undiluted cDNA allowed to adhere overnight. Cells were then washed twice and
fresh media lacking tetracycline was added. Thirty minutes prior toat time 0), the area taken up by actin was normalized relative to the
area of the most intense actin band in the series. The resulting harvesting, the cultures were pulsed with 10 mM BrdU. After staining
fixed cells with 10 mL FITC-conjugated anti-BrdU and 5 mg/ml pro-ªnormalization coefficientº was used to normalize the areas calcu-
lated for the other Slfn products in that cDNA sample. pidium iodide (Dolbeare et al., 1983), they were analyzed by flow
cytometry.
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